Radiation Oncology

Radiation oncology is a medical specialty that uses radiation therapy to treat cancer. The radiation therapy channel covers all aspects of radiation oncology technology. Radiation therapy includes linear accelerators (LINAC), proton therapy, brachytherapy, image guided radiation therapy (IGRT), focused ultrasound, stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), treatment planning systems and tomotherapy.

Under this agreement Apollo Healthcare will provide its Prior-Authorization package, amongst other services to ART’s existing customer base, as well as any healthcare facilities considering use of their products such as PreciseRT and AccuBoost for adoption within their clinical patient treatment armamentariums.
News | Radiation Therapy
Advanced Radiation Therapy, LLC and Apollo Healthcare Announce Strategic Partnership

October 21, 2021 — Advanced Radiation Therapy, LLC (ART) and Apollo Healthcare have announced a strategic partnership ...

Time October 21, 2021
arrow
The Persona CT, a leading-edge CT system with an 85-cm bore that offers advanced oncology simulation and general radiography imaging capabilities
News | Radiation Oncology
Fujifilm Showcases Comprehensive Radiation Oncology Portfolio at ASTRO 2021

October 21, 2021 — Fujifilm Healthcare Americas, a leading provider of diagnostic imaging and medical informatics ...

Time October 21, 2021
arrow
On behalf of the nation's radiation oncologists and the more than one million people with cancer they will treat this year, the American Society for Radiation Oncology (ASTRO) expressed strong support for today's Senate introduction of bipartisan federal legislation that would rein in restrictive prior authorization practices that delay patient access to critical cancer treatments.
News | Radiation Oncology
ASTRO Backs Bipartisan Congressional Bills to Reduce Prior Authorization Burdens and Treatment Delays for People with Cancer

October 20, 2021 — On behalf of the nation's radiation oncologists and the more than one million people with cancer they ...

Time October 20, 2021
arrow
IBA announced the launch of the world’s first online platform dedicated to proton therapy. The new interactive platform called Campus was unveiled through a series of webinars on October 19-20, 2021. It will also be showcased at the American Society for Radiation Oncology (ASTRO) Annual Meeting
News | Proton Therapy
IBA Launches the World’s First Online Proton Therapy Platform

October 20, 2021 — IBA (Ion Beam Applications SA), the world leader in particle accelerator technology and the world’s ...

Time October 20, 2021
arrow
New research in the October 2021 issue of JNCCN—Journal of the National Comprehensive Cancer Network assessed patient satisfaction and preferences for telemedicine, finding 45% of people with cancer preferred telemedicine, while 34% preferred office visits, and 21% had no preference.
News | Teleradiology
More People with Cancer Undergoing Radiotherapy Prefer Telemedicine to In-person Visits

October 20, 2021 — New research in the October 2021 issue of JNCCN—Journal of the National Comprehensive Cancer Network ...

Time October 20, 2021
arrow
RefleXion is developing biology-guided radiotherapy* (BgRT), which incorporates positron-emission tomography (PET) data to enable tumors to continuously signal their location. The BgRT technology will synchronize these data with the linear accelerator to direct radiotherapy to tumors with sub-second latency. Currently, the RefleXion X1 machine is cleared for the delivery of stereotactic body radiotherapy (SBRT), stereotactic radiosurgery (SRS) and intensity modulated radiotherapy (IMRT).
News | Radiation Oncology
RefleXion Announces Newly Formed Scientific Advisory Board

October 20, 2021 — RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy (BgRT) as a ...

Time October 20, 2021
arrow
RAD Technology Medical Systems provides complex, design-built modular facilities for the healthcare industry. #ASTRO #ASTRO21
News | Radiation Therapy
RAD Technology Medical Systems to Exhibit at the ASTRO 2021

October 19, 2021 — RAD Technology Medical Systems (RAD) announced that it will be exhibiting at the 2021 American ...

Time October 19, 2021
arrow
Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, announced presentations on Axumin (fluciclovine F 18) and 18F-fluciclovine at the upcoming American Society for Radiation Oncology (ASTRO) 2021 Annual Meeting
News | PET Imaging
Blue Earth Diagnostics Highlights Presentations on Axumin (Fluciclovine F 18) and 18F-Fluciclovine at ASTRO21

October 19, 2021 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time October 19, 2021
arrow
MR images showing reduction in size of metastatic tumors after focused-ultrasound delivery of antibody therapy through blood-brain barrier.
News | Ultrasound Women's Health
World-first Clinical Trial Demonstrates Focused Ultrasound Can Deliver Antibody Therapy to Breast Cancer Metastases in the Brain

October 14, 2021 — In a first-in-world clinical trial, researchers at Sunnybrook Health Sciences Centre in Toronto ...

Time October 14, 2021
arrow
(A) Pre-procedure axial image from contrast-enhanced CT scan of chest demonstrates a 1 cm solid right upper lobe nodule adjacent to right mainstem bronchus (arrow). (B) Intra-procedural coronal reformatted image shows two cryoablation probes within nodule. (C) 1-month follow-up sagittal chest CT image shows expected post-ablation changes encompassing treated nodule (arrow). (D) 1-year follow-up sagittal chest CT image shows expected involution of treatment zone into flat bandlike scar without residual tumor
News | Lung Imaging
Percutaneous Image-Guided Microwave and Cryoablation for Lung Sarcoma

October 11, 2021 — According to ARRS’ American Journal of Roentgenology (AJR), percutaneous image-guided microwave and ...

Time October 11, 2021
arrow
Sun Nuclear's SunCHECK Platform enables comprehensive remote quality assurance (QA) for radiation therapy, during COVID-19 and beyond.
News | Quality Assurance (QA)
ITN Launches New Comparison Chart on Radiation Therapy QA

October 11, 2021 — To maintain safety in radiation therapy (RT), every machine performance and patient delivery ...

Time October 11, 2021
arrow
An analysis of nearly 200,000 patients highlights the heterogeneity of breast cancer risk factors for women of differing races, ages, and disease subtypes
News | Women's Health
Black Women Face Three-fold Increased Risk of Triple Negative Breast Cancers

October 8, 2021 — An analysis of nearly 200,000 patients who received mammograms between 2006 and 2015 across three U.S ...

Time October 08, 2021
arrow
NBTXR3 is a novel, potentially first-in-class oncology product composed of functionalized hafnium oxide nanoparticles that is administered via one-time intratumoral injection and activated by radiotherapy.
News | Radiation Therapy
NANOBIOTIX to Present First Survival Data From Priority Head and Neck Cancer Program at ASTRO21

October 7, 2021 — NANOBIOTIX, a late-stage clinical biotechnology company pioneering physics-based approaches to expand ...

Time October 07, 2021
arrow
ViewRay, Inc. announced that the company has received acceptance from the FDA on their recent submission for new MRIdian features focused on enhancing on-table adaptive workflow efficiency and expanding clinical utility. ViewRay will be exhibiting at the annual ASTRO 2021 conference
News | Radiation Therapy
ViewRay Announces 510(k) Pending Status of the Newest Generation of MRIdian Innovations

October 7, 2021 — ViewRay, Inc. announced that the company has received acceptance from the FDA on their recent ...

Time October 07, 2021
arrow
Images of uptake in bone metastasis in patient 2. Anterior whole-body (left) and SPECT/CT (right) images show uptake of 131I-GMIB-anti-HER2-VHH1 at level of large lytic bone metastasis, with soft-tissue component at sternal bone both at 2.5 h and at 24 h after injection. Small differences in area of uptake are explained by differences in patient positioning (arms up at 2.5 h and arms down at 24 h, to maximize patient comfort). Cts = counts. Image created by M. Keyaerts, University Hospital of Brussels (UZ B
News | Women's Health
New Radionuclide Therapy Identified for HER2-positive Breast Cancer Patients

October 5, 2021 — A promising radionuclide treatment may offer new therapeutic options for breast cancer patients ...

Time October 05, 2021
arrow
Sun Nuclear’s SunCHECK Patient QA uses calibrated EPID data to enable true dosimetric in-vivo monitoring, creating a fully independent absolute dosimetric QA of patient treatments.
Feature | Radiation Therapy | By Dave Fornell
The Importance of Radiation Oncology Quality Assurance Systems for Safe and Accurate Treatment Delivery

To maintain safety in radiation therapy (RT), every machine performance and patient delivery measurement must be as ...

Time October 05, 2021
arrow
According to the American Cancer Society, around 10-15% of breast cancers are triple-negative breast cancer.
News | Breast Imaging
Georgia Cancer Center Researcher Receives $1.7M Grant to Study Aggressive Form of Breast Cancer 
October 4, 2021 — Understanding the role a certain molecule plays in both cancer cells, as well as the cells tasked to ...
Time
arrow
Gadolinium-enhanced MRI of a cardiac radiation therapy patient at baseline (left) and 3 months post-treatment (right). Top: the left ventricle with patchy, gadolinium-enhanced scar was transmurally targeted with a radiation ose of 25 Gy between 3 and 6 o’clock (red brackets). Nonenhanced, remote myocardium is adjacent to target region (white arrowhead). Bottom: surviving nonenhanced myocardium within the same images is visible in the targeted region at baseline and 3 months post-treatment (yellow outline).
Feature | Radiation Therapy
Radiation Therapy Reprograms Heart Cells to Younger State

September 28, 2021 — New research from Washington University School of Medicine in St. Louis suggests that radiation ...

Time September 28, 2021
arrow
The global radiotherapy devices market is expected to grow from $5.44 billion in 2020 to $5.848 billion in 2021 at a compound annual growth rate (CAGR) of 7.5%
News | Radiation Oncology
Global $5.8 Billion Radiotherapy Devices 2021 Market Report

September 28, 2021 — The global radiotherapy devices market is expected to grow from $5.44 billion in 2020 to $5.848 ...

Time September 28, 2021
arrow
Scientists have identified two subtypes of metastatic prostate cancer that respond differently to treatment, information that could one day guide physicians in treating patients with the therapies best suited to their disease.
News | Prostate Cancer
Metastatic Prostate Cancer Comes in Two Forms, Which Could Guide Treatment

September 24, 2021 — Scientists have identified two subtypes of metastatic prostate cancer that respond differently to ...

Time September 24, 2021
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now